SG Americas Securities’s Omega Protein OME Stock Holding History

SG Americas Securities’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-17,169	Closed	-$286K	–	3906
2017 Q3	$286K	Buy	17,169 +9,675	+129%	+$157K	﹤0.01%	2282
2017 Q2	$134K	Sell	7,494 -598	-7%	-$11.2K	﹤0.01%	2717
2017 Q1	$162K	Sell	8,092 -2,752	-25%	-$64.1K	﹤0.01%	2606
2016 Q4	$272K	Buy	10,844 +4,081	+60%	+$96.4K	﹤0.01%	2121
2016 Q3	$158K	Buy	+6,763	New	+$159K	﹤0.01%	2684
2016 Q2	–	Sell	-8,892	Closed	-$151K	–	3216
2016 Q1	$151K	Buy	+8,892	New	+$182K	﹤0.01%	2367
2015 Q2	–	Sell	-9,160	Closed	-$125K	–	2971
2015 Q1	$125K	Buy	+9,160	New	+$106K	﹤0.01%	2145
2014 Q1	–	Sell	-22,384	Closed	-$275K	–	2922
2013 Q4	$275K	Buy	+22,384	New	+$263K	﹤0.01%	1900

SG Americas Securities's OME Position: Q4 2017 in Review

SG Americas Securities sold out of Omega Protein (OME) in Q4 2017, closing a stake of 17,169 shares — an estimated $286K sold.

SG Americas Securities first reported a position in OME in Q4 2013 and held it in 8 quarters. The position peaked at $286K in Q3 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

SG Americas Securities reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
SG Americas Securities sold 17,169 Omega Protein shares in Q4 2017, an estimated $286K.
SG Americas Securities first reported a position in Omega Protein in Q4 2013 and held it in 8 quarters.
SG Americas Securities's Omega Protein position peaked at $286K in Q3 2017.
0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on SG Americas Securities's 13F filing for Q4 2017, filed 24 Jan 2018.